Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 A case for treating high hepatitis B DNA levels before starting HIV therapy.

Literature DB >> 17117033

A case for treating high hepatitis B DNA levels before starting HIV therapy.

Jason V Baker, David R Boulware, Paul R Bohjanen.

Abstract

Mesh：

Substances：

Year: 2006 PMID： 17117033 PMCID： PMC1940776 DOI： 10.1097/QAD.0b013e3280110aef

Source DB: PubMed Journal: AIDS ISSN： 0269-9370 Impact factor: 4.177

× No keyword cloud information.

13 in total

1. BHIVA Guidelines: coinfection with HIV and chronic hepatitis B virus.

Authors: M G Brook; R Gilson; E L Wilkins
Journal: HIV Med Date: 2003-10 Impact factor: 3.180

Review 2. The immune reconstitution inflammatory syndrome.

Authors: Samuel A Shelburne; Richard J Hamill
Journal: AIDS Rev Date: 2003 Apr-Jun Impact factor: 2.500

Review 3. Care of patients with chronic hepatitis B and HIV co-infection: recommendations from an HIV-HBV International Panel.

Authors: Vincent Soriano; Massimo Puoti; Maurizio Bonacini; Gary Brook; Antonietta Cargnel; Juergen Rockstroh; Chloe Thio; Yves Benhamou
Journal: AIDS Date: 2005-02-18 Impact factor: 4.177

4. Entecavir.

Authors: Christopher K Opio; William M Lee; Peter Kirkpatrick
Journal: Nat Rev Drug Discov Date: 2005-07 Impact factor: 84.694

5. Acute clinical hepatitis in an HIV-seropositive hepatitis B carrier receiving protease inhibitor therapy.

Authors: C M Mastroianni; V Trinchieri; P Santopadre; M Lichtner; G Forcina; C D'Agostino; A Corpolongo; V Vullo
Journal: AIDS Date: 1998-10-01 Impact factor: 4.177

6. Restoration of immunity to chronic hepatitis B infection in HIV-infected patient on protease inhibitor.

Authors: A Carr; D A Cooper
Journal: Lancet Date: 1997-04-05 Impact factor: 79.321

7. Incidence and risk factors of immune reconstitution inflammatory syndrome complicating HIV-associated cryptococcosis in France.

Authors: Olivier Lortholary; Arnaud Fontanet; Nathalie Mémain; Antoine Martin; Karine Sitbon; Françoise Dromer
Journal: AIDS Date: 2005-07-01 Impact factor: 4.177

8. Paradoxical worsening of tuberculosis in HIV-infected persons.

Authors: K A Wendel; K S Alwood; R Gachuhi; R E Chaisson; W R Bishai; T R Sterling
Journal: Chest Date: 2001-07 Impact factor: 9.410

9. Incidence and risk factors for immune reconstitution inflammatory syndrome during highly active antiretroviral therapy.

Authors: Samuel A Shelburne; Fehmida Visnegarwala; Jorge Darcourt; Edward A Graviss; Thomas P Giordano; A Clinton White; Richard J Hamill
Journal: AIDS Date: 2005-03-04 Impact factor: 4.177

10. Immune reconstitution hepatitis in HIV and hepatitis B coinfection, despite lamivudine therapy as part of HAART.

Authors: Anne Drake; Anne Mijch; Joe Sasadeusz
Journal: Clin Infect Dis Date: 2004-06-01 Impact factor: 9.079

4 in total

Review 1. Management of the immune reconstitution inflammatory syndrome.

Authors: Graeme Meintjes; James Scriven; Suzaan Marais
Journal: Curr HIV/AIDS Rep Date: 2012-09 Impact factor: 5.071

2. Biomarkers of HIV Immune Reconstitution Inflammatory Syndrome.

Authors: Shuli Bonham; David B Meya; Paul R Bohjanen; David R Boulware
Journal: Biomark Med Date: 2008 Impact factor: 2.851

3. Biomarkers of inflammation and coagulation are associated with mortality and hepatitis flares in persons coinfected with HIV and hepatitis viruses.

Authors: Bruno Bezerril Andrade; Katherine Huppler Hullsiek; David R Boulware; Adam Rupert; Martyn A French; Kiat Ruxrungtham; Marisa Luisa Montes; Huw Price; Pablo Barreiro; Jennifer Audsley; Alan Sher; Sharon R Lewin; Irini Sereti
Journal: J Infect Dis Date: 2013-01-18 Impact factor: 5.226

Review 4. Management of patients with the immune reconstitution inflammatory syndrome.

Authors: Suzaan Marais; Robert J Wilkinson; Dominique J Pepper; Graeme Meintjes
Journal: Curr HIV/AIDS Rep Date: 2009-08 Impact factor: 5.495

4 in total